Hillsdale Investment Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.75M | Buy |
264,800
+67,700
| +34% | +$1.47M | 0.21% | 118 |
|
|
2025
Q1 | $4.78M | Buy |
197,100
+7,100
| +4% | +$172K | 0.24% | 73 |
|
|
2024
Q4 | $3.97M | Buy |
190,000
+100
| +0.1% | +$2.09K | 0.2% | 133 |
|
|
2024
Q3 | $3.78M | Buy |
+189,900
| New | +$3.78M | 0.29% | 137 |
|
|
2024
Q1 | – | Sell |
-280
| Closed | -$4.71K | – | 606 |
|
|
2023
Q4 | $4.71K | Sell |
280
-80
| -22% | -$1.35K | ﹤0.01% | 541 |
|
|
2023
Q3 | $4.21K | Sell |
360
-254,960
| -100% | -$2.98M | ﹤0.01% | 544 |
|
|
2023
Q2 | $3.43M | Sell |
255,320
-80,580
| -24% | -$1.08M | 0.32% | 135 |
|
|
2023
Q1 | $5.57M | Sell |
335,900
-23,900
| -7% | -$396K | 0.48% | 64 |
|
|
2022
Q4 | $6.69M | Sell |
359,800
-121,900
| -25% | -$2.27M | 0.57% | 32 |
|
|
2022
Q3 | $6.18M | Sell |
481,700
-173,900
| -27% | -$2.23M | 0.56% | 39 |
|
|
2022
Q2 | $4.6M | Buy |
655,600
+5,700
| +0.9% | +$40K | 0.37% | 95 |
|
|
2022
Q1 | $5.39M | Buy |
+649,900
| New | +$5.39M | 0.35% | 93 |
|
|
2018
Q1 | – | Sell |
-17,000
| Closed | -$66K | – | 482 |
|
|
2017
Q4 | $66K | Buy |
+17,000
| New | +$66K | 0.01% | 307 |
|